Project co-financed by the European Union, the Italian State and Regione Campania, as part of the POR Campania ERDF 2014-2020 with a subsidy in the form of a grant. The Antitumor Drugs and Vaccines from the SEa (ADViSE) Project, with the code 1706BP000000011, aims to provide a new perspective of innovation in drug discovery processes for the fight against oncological pathologies (LC, Mel, MMi) *, by activating a new modality of collaboration between the world of research and innovation, through: 1. The development of antitumoral vaccine models; 2. the identification of new chemotherapy molecules also provided with immunomodulating activity of natural origin. To achieve this goal, the aim is to create a regional experimentation hub for the early identification of tumors, the characterization of the resistance profile and the creation of alternative therapies for patients who do not respond to conventional therapies. With these premises, the purposes of the ADViSE Platform are: Preclinical development of new chemotherapeutical agents with immunomodulating action, based on the principle of combining the two actions, using a platform for the selection and validation of oncological drug discovery, which already in the past, in…